Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · IEX Real-Time Price · USD
21.98
-0.12 (-0.54%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Rocket Pharmaceuticals Employees
Rocket Pharmaceuticals had 268 employees on December 31, 2023. The number of employees increased by 28 or 11.67% compared to the previous year.
Employees
268
Change (1Y)
28
Growth (1Y)
11.67%
Revenue / Employee
n/a
Profits / Employee
-$916,399
Market Cap
1.99B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 268 | 28 | 11.67% |
Dec 31, 2022 | 240 | 89 | 58.94% |
Dec 31, 2021 | 151 | 60 | 65.93% |
Dec 31, 2020 | 91 | 34 | 59.65% |
Dec 31, 2019 | 57 | 24 | 72.73% |
Dec 31, 2018 | 33 | 13 | 65.00% |
Dec 31, 2017 | 20 | -4 | -16.67% |
Dec 31, 2016 | 24 | 7 | 41.18% |
Dec 31, 2015 | 17 | 12 | 240.00% |
Dec 31, 2014 | 5 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Owens & Minor | 22,200 |
CONMED | 4,000 |
Amphastar Pharmaceuticals | 1,761 |
Intellia Therapeutics | 526 |
RxSight | 374 |
Sana Biotechnology | 328 |
Kymera Therapeutics | 187 |
Dyne Therapeutics | 123 |
RCKT News
- 24 days ago - Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia - Business Wire
- 4 weeks ago - Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership Team - Business Wire
- 2 months ago - Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress - Business Wire
- 2 months ago - Rocket Pharmaceuticals Announces Update on FDA Review Timeline of KRESLADI™ (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) - Business Wire
- 4 months ago - Rocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference - Business Wire
- 4 months ago - Best Small-Cap Stocks to Buy for 2024 and Beyond - Kiplinger
- 4 months ago - Rocket Pharmaceuticals Appoints R. Keith Woods to Board of Directors - Business Wire
- 6 months ago - Rocket Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Progress - Business Wire